Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 73.62 -0.88%   SPY: 165.93 -0.74%
Discuss Index Tracked By  


  Track the *RXDLV Index  

Drug Delivery Stocks (*RXDLV)

  Drug Delivery Ideas       Drug Delivery Performance       Drug Delivery Community  
 
Popular long ideas:
Popular short ideas:
Top dividend plays:
Pro favorites:
VRX, BDSI, APRI
VRX, HSP, DRRX
None
VRX, HSP, ALKS
 
Index Description: Companies that focus on technology for delivering pharmaceuticals - pills, patches, sprayes and more are represented here
     
Today:
1-month:
All-time:
+0.3%
+0.1%
+37.1%
vs S&P 500:
vs S&P 500:
vs S&P 500:
+1.0%
-5.1%
+17.0%
Data since: Jan-01-2008
 
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
$3.1B
12.4
0.0%
     
74 members Tracking
Share this Index on Facebook
Share this Index on Twitter
 
                     
     
 
Chart View
1 week
 
1 month
 
3 months
 
6 months
 
All Time
 
 
 
 
 
 
 
   
     
 
Portfolio Detail
 
  Standard View     Performance View     Ideas & Research    
Click a column to sort | Scroll over columns for more information
 
 Ticker Last Trade Today's Change Volume  % of
Daily
Mkt Cap  Div Yield  % off
52wk lw
% from
52wk hg
Alerts
 ACRX $7.26 +0.86 +13.4% 996,826 275% $270.3M - 220% -2% No Alerts/News
 ALKS $31.75 -0.23 -0.7% 1,550,166 92% $4.2B - 114% -4% No Alerts/News
 APRI $3.30 -0.11 -3.2% 657,170 221% $100.1M - 75% -9% 2 Alerts (2 News) - View
 BDSI $4.20 -0.14 -3.2% 332,828 135% $159.5M - 35% -39% 1 Alert (0 News) - View
 CBRX $0.62 0.00 0.0% 175,546 57% $54.2M - 13% -50% No Alerts/News
 DRRX $0.91 -0.04 -4.4% 550,100 62% $92.5M - 49% -51% 1 Alert (0 News) - View
 FLML $4.63 -0.02 -0.4% 27,929 53% $115.5M - 62% -18% No Alerts/News
 HSP $35.40 -0.52 -1.4% 933,066 68% $5.8B - 24% -6% No Alerts/News
 KVPHQ $0.12 +0.01 +9.1% 36,333 32% $7.1M - 362% -92% No Alerts/News
 NKTR $9.24 -0.49 -5.0% 1,888,638 199% $1.0B - 64% -19% 1 Alert (0 News) - View
 VRX $74.82 -0.71 -0.9% 871,930 70% $22.7B - 76% -5% No Alerts/News
Is this index incomplete or incorrect?
Got an idea for a new Index?
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
DGAP-News: Apricus Biosciences Announces Proposed Public Offering of Common Stock and Warrants
APRI  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 22, 04:13PM from (globenewswire.com)

Apricus Biosciences, Inc.

22.05.2013 22:01
---------------------------------------------------------------------------
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Apricus Biosciences Announces Proposed Public Offering of Common Stock and Warrants
APRI  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 22, 04:13PM from (globenewswire.com)
SAN DIEGO, May 22, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company")  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
A Good Deal For Actavis, But Warner Chilcott Goes A Little Cheap
MYL  ACT  VRX  WCRX  
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - May 21, 02:00PM from (www.investopedia.com)
Actavis gets a very useful asset, while Warner Chilcott shareholders get a decent exit.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pharma M&A – Actavis to Acquire Warner Chilcott
FRX  MYL  TEVA  ACT  VRX  WCRX  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 20, 11:32AM from (www.benzinga.com)
On Monday, generic drug maker Actavis Inc. (NYSE: ACT) announced plans to purchase specialty pharmaceutical company Warner  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
DealBook: Actavis to Buy Warner Chilcott in All-Stock Deal
MYL  VRX  WCRX  
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 20, 08:16AM from (dealbook.nytimes.com)
Actavis, a maker of generic drugs, agreed to buy the specialty pharmaceutical company Warner Chilcott for about $5 billion  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
'Love Hormone' Promises Safer Births After Pfizer Flop
PFE  MNKD  NKTR  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 19, 06:03PM from (www.bloomberg.com)
A hormone treatment based on technology used in Pfizer Inc. (PFE)’s failed inhalable insulin shows promise in fighting the leading cause of maternal mortality.
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2013
ALKS  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 16, 04:00PM from (www.businesswire.com)
Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:00 a.m. EDT (1:00 p.m. BST) on Thursday, May 23, 2013, to discuss  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Alkermes Elects Nancy Wysenski to Board of Directors
ALKS  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 16, 07:00AM from (www.businesswire.com)
Alkermes plc (NASDAQ: ALKS) today announced the election of Nancy J. Wysenski to the company’s Board of Directors. Most  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Summary of Jana Partners 13F: Aetna, Expedia and Kinder Morgan All Raised Among Others
AIG  BA  KO  SVU  FNP  BIG  ODP  WM  BMC  SYMC  IACI  CPRT  TK  AGU  OPK  VRSN  IRM  CVG  AXL  NFLX  VC  AET  HSP  ASH  ROC  EXPE  LYV  SE  KAR  DTV  LINTA  QEP  SEMG  KMI  GRPN  ZNGA  TRIP  ADT  FANG  LMCA  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 15, 03:24PM from (www.benzinga.com)
Barry Rosenstein's JANA Partners released its 13F for Q1 Wednesday.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
What We're Reading ~ Analytical Links 5/15/13
VZ  VOD  DLTR  HSP  FLT  
Linked by market folly ( track newsfeed | ignore newsfeed ) - May 15, 01:05PM from (www.marketfolly.com)
Meb Faber's new book: Shareholder Yield [Meb Faber]



Explanation of Tepper's chart: Equity risk premium is high (this is bullish) [The Big Picture]
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Michael Price's Presentation at London Value Conference: Long Hospira & Hess
HES  HSP  BRK.A  
Linked by market folly ( track newsfeed | ignore newsfeed ) - May 13, 01:52PM from (www.marketfolly.com)
Continuing our notes from the London Value Investor Conference 2013, the next speaker is Michael Price of MFP Investors.   more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
The Week Ahead: Full Slate of Economic Data; Earnings From Cisco, Wal-Mart and Deere
SSI  BWS  JWN  WMT  DE  ACAT  ADSK  M  PLAB  CSCO  ALKS  KSS  SSYS  TTWO  BRCD  SKX  A  SINA  NTES  JCP  ARUN  IOC  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 10, 09:59PM from (www.benzinga.com)
A host of economic data is set to be released for the week beginning May 13. Investors will also continue to be focused on  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Mid-Morning Market Update: Gold Futures See Sharp Decline, Ubiquity Networks Reports Growth for Second Straight Quarter
PFE  PTIE  DRRX  IFMI  TSLA  MCP  
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 10, 10:47AM from (www.benzinga.com)
Following the market opening Friday, the Dow traded up 0.13 percent to 15,102.64, while the NASDAQ gained 0.42 percent to  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Apricus Biosciences Provides First Quarter 2013 Corporate Update
APRI  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 10, 08:43AM from (globenewswire.com)
SAN DIEGO, May 10, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company")  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
DGAP-News: Apricus Biosciences Provides First Quarter 2013 Corporate Update
APRI  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 10, 08:43AM from (globenewswire.com)

Apricus Biosciences, Inc.

10.05.2013 14:30
---------------------------------------------------------------------------
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Adasuve Deal Is Very Good For Alexza, But What About Teva?
BMY  LLY  TEVA  VRX  ALXA  
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - May 09, 04:45PM from (www.investopedia.com)
Teva's partnership with Alexza looks like an expensive gamble.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Nektar Therapeutics Reports Financial Results for the First Quarter of 2013
NKTR  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 09, 04:15PM

SAN FRANCISCO, May 9, 2013 /PRNewswire/ -- Nektar Therapeutics  more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Hospira Sues B. Braun Over Infusion-Pump System Patents
HSP  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 09, 11:09AM from (www.bloomberg.com)
Hospira Inc. (HSP), a maker of acute-care products, sued a U.S. unit of Germany’s B. Braun Melsungen AG alleging infringement of patents for drug-infusion pump technology.
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results
ACRX  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 08, 04:05PM

REDWOOD CITY, Calif., May 8, 2013 /PRNewswire/ -- AcelRx  more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 41



Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.

Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.

Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.

Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.

Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.

Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.

Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
tickerspy Indexes use a "net asset value" calculation. The components are equally weighted at the inception of the Index (typically 1/1/2008) and over time as some stocks go up and others go down, the relative weights of the components shift accordingly.
Click to close X

We look at the recent net stock adds (people adding a stock to their portfolio minus people removing it) and compare against the company's previous history to identify those companies that are seeing the largest changes on a relative basis. Without the company history comparison, our most followed companies would likely be near the top of the list at all times. A value greater than one indicates a greater than normal number of adds over the last seven days, and a value less than one indicates a less than normal number of adds. If no value is shown, there was not enough activity to generate a value.

Click to close X

We look at the recent net stock shorts (people shorting it in their portfolios minus people covering their short) and compare against the company's previous history to identify those companies that are seeing the largest changes on a relative basis. A value less than -1 (for example -3.6) indicates a greater than normal number of shorts over the last seven days, and a value greater than -1 (for example -0.6) indicates a less than normal number of adds. If no value is shown, there was not enough activity to generate a value.

Click to close X

Thanks for helping us keep tickerspy Indexes accurate!

Let us know which tickers should be added or removed from the Drug Delivery Stocks Index (*RXDLV).

Note: Our tickerspy research team will look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.


Click to close X

Got an idea for an Index we don't have listed? Send it, and our research team will consider it for inclusion.

Note: Our tickerspy research team look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.

Index Name

Tickers(separate with spaces or commas)

Additional comments